BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 38660802)

  • 21. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
    Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of myxomatous mitral valve disease in the dog.
    Fox PR
    J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitral valve disease in Marfan syndrome and related disorders.
    Judge DP; Rouf R; Habashi J; Dietz HC
    J Cardiovasc Transl Res; 2011 Dec; 4(6):741-7. PubMed ID: 21866385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling pathways in mitral valve degeneration.
    Orton EC; Lacerda CM; MacLea HB
    J Vet Cardiol; 2012 Mar; 14(1):7-17. PubMed ID: 22364692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.